{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:55:24Z","timestamp":1789617324586,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["SUB\/1\/DN\/19\/004\/1208"],"award-info":[{"award-number":["SUB\/1\/DN\/19\/004\/1208"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s12020-020-02596-8","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T05:57:48Z","timestamp":1610603868000},"page":"400-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Metabolic syndrome and the risk of cardiovascular complications in young patients with different phenotypes of polycystic ovary syndrome"],"prefix":"10.1007","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5959-5481","authenticated-orcid":false,"given":"Anna","family":"Krentowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4898-0629","authenticated-orcid":false,"given":"Agnieszka","family":"\u0141ebkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4669-8945","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Jacewicz-\u015awi\u0119cka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3894-3218","authenticated-orcid":false,"given":"Justyna","family":"Hryniewicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Le\u015bniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2544-130X","authenticated-orcid":false,"given":"Agnieszka","family":"Adamska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9281-1959","authenticated-orcid":false,"given":"Irina","family":"Kowalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"issue":"5","key":"2596_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"H.F. Escobar-Morreale, Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat. Rev. Endocrinol. 14(5), 270\u2013284 (2018). https:\/\/doi.org\/10.1038\/nrendo.2018.24","journal-title":"Nat. Rev. Endocrinol."},{"key":"2596_CR2","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19(1), 41\u201347 (2004)","DOI":"10.1093\/humrep\/deh098"},{"issue":"16","key":"2596_CR3","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/circulationaha.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16), 1640\u20131645 (2009). https:\/\/doi.org\/10.1161\/circulationaha.109.192644","journal-title":"Circulation"},{"issue":"2","key":"2596_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/obr.12762","volume":"20","author":"SS Lim","year":"2019","unstructured":"S.S. Lim, N.S. Kakoly, J.W.J. Tan, G. Fitzgerald, M. Bahri Khomami, A.E. Joham, S.D. Cooray, M.L. Misso, R.J. Norman, C.L. Harrison, S. Ranasinha, H.J. Teede, L.J. Moran, Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes. Rev. 20(2), 339\u2013352 (2019). https:\/\/doi.org\/10.1111\/obr.12762","journal-title":"Obes. Rev."},{"issue":"1","key":"2596_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.fertnstert.2018.09.013","volume":"111","author":"S Zhu","year":"2019","unstructured":"S. Zhu, B. Zhang, X. Jiang, Z. Li, S. Zhao, L. Cui, Z.J. Chen, Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil. Steril. 111(1), 168\u2013177 (2019). https:\/\/doi.org\/10.1016\/j.fertnstert.2018.09.013","journal-title":"Fertil. Steril."},{"issue":"1","key":"2596_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","volume":"17","author":"D Glintborg","year":"2018","unstructured":"D. Glintborg, K.H. Rubin, M. Nybo, B. Abrahamsen, M. Andersen, Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome. Cardiovasc. Diabetol. 17(1), 37 (2018). https:\/\/doi.org\/10.1186\/s12933-018-0680-5","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"2596_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/cen.14117","volume":"92","author":"C Meun","year":"2020","unstructured":"C. Meun, M.N. Gunning, Y.V. Louwers, H. Peters, J. Roos-Hesselink, J. Roeters van Lennep, O.L. Rueda Ochoa, Y. Appelman, N. Lambalk, E. Boersma, M. Kavousi, B.C. Fauser, J.S. Laven, The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 92(2), 150\u2013158 (2020). https:\/\/doi.org\/10.1111\/cen.14117","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"9","key":"2596_CR8","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1089\/jwh.2015.5441","volume":"25","author":"CN Merz","year":"2016","unstructured":"C.N. Merz, L.J. Shaw, R. Azziz, F.Z. Stanczyk, G. Sopko, G.D. Braunstein, S.F. Kelsey, K.E. Kip, R.M. Cooper-DeHoff, B.D. Johnson, V. Vaccarino, S.E. Reis, V. Bittner, T.K. Hodgson, W. Rogers, C.J. Pepine, Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome. J. Women\u2019s Health (Larchmt.) 25(9), 875\u2013881 (2016). https:\/\/doi.org\/10.1089\/jwh.2015.5441","journal-title":"J. Women\u2019s Health (Larchmt.)"},{"issue":"5","key":"2596_CR9","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"R.A. Wild, E. Carmina, E. Diamanti-Kandarakis, A. Dokras, H.F. Escobar-Morreale, W. Futterweit, R. Lobo, R.J. Norman, E. Talbott, D.A. Dumesic, Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95(5), 2038\u20132049 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2724","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2596_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2013.01.025","volume":"228","author":"SC van den Oord","year":"2013","unstructured":"S.C. van den Oord, E.J. Sijbrands, G.L. ten Kate, D. van Klaveren, R.T. van Domburg, A.F. van der Steen, A.F. Schinkel, Carotid intima-media thickness for cardiovascular risk assessment: systematic review and meta-analysis. Atherosclerosis 228(1), 1\u201311 (2013). https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.025","journal-title":"Atherosclerosis"},{"issue":"1","key":"2596_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijcard.2012.09.047","volume":"168","author":"RT Ras","year":"2013","unstructured":"R.T. Ras, M.T. Streppel, R. Draijer, P.L. Zock, Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J. Cardiol. 168(1), 344\u2013351 (2013). https:\/\/doi.org\/10.1016\/j.ijcard.2012.09.047","journal-title":"Int J. Cardiol."},{"issue":"3","key":"2596_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2265.2012.04490.x","volume":"78","author":"VS Sprung","year":"2013","unstructured":"V.S. Sprung, G. Atkinson, D.J. Cuthbertson, C.J. Pugh, N. Aziz, D.J. Green, N.T. Cable, H. Jones, Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies. Clin. Endocrinol. (Oxf.) 78(3), 438\u2013446 (2013). https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04490.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"2","key":"2596_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/humupd\/dmr046","volume":"18","author":"ML Meyer","year":"2012","unstructured":"M.L. Meyer, A.M. Malek, R.A. Wild, M.T. Korytkowski, E.O. Talbott, Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 18(2), 112\u2013126 (2012). https:\/\/doi.org\/10.1093\/humupd\/dmr046","journal-title":"Hum. Reprod. Update"},{"issue":"4","key":"2596_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/cen.14063","volume":"91","author":"E Carmina","year":"2019","unstructured":"E. Carmina, M.P. Nasrallah, E. Guastella, R.A. Lobo, Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily. Clin. Endocrinol. (Oxf.) 91(4), 553\u2013560 (2019). https:\/\/doi.org\/10.1111\/cen.14063","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"11","key":"2596_CR15","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/humrep\/dex294","volume":"32","author":"R Pelanis","year":"2017","unstructured":"R. Pelanis, J.R. Mellembakken, I. Sundstrom-Poromaa, P. Ravn, L. Morin-Papunen, J.S. Tapanainen, T. Piltonen, J. Puurunen, A.L. Hirschberg, P. Fedorcsak, M. Andersen, D. Glintborg, The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS. Hum. Reprod. 32(11), 2279\u20132286 (2017). https:\/\/doi.org\/10.1093\/humrep\/dex294","journal-title":"Hum. Reprod."},{"issue":"12","key":"2596_CR16","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s40618-018-0902-4","volume":"41","author":"L Zhang","year":"2018","unstructured":"L. Zhang, X. Fang, L. Li, R. Liu, C. Zhang, H. Liu, M. Tan, G. Yang, The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome. J. Endocrinol. Invest. 41(12), 1401\u20131407 (2018). https:\/\/doi.org\/10.1007\/s40618-018-0902-4","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"2596_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12020-011-9437-6","volume":"39","author":"B Dilbaz","year":"2011","unstructured":"B. Dilbaz, E. Ozkaya, M. Cinar, E. Cakir, S. Dilbaz, Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. Endocrine 39(3), 272\u2013277 (2011). https:\/\/doi.org\/10.1007\/s12020-011-9437-6","journal-title":"Endocrine"},{"issue":"11","key":"2596_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"D. Ferriman, J.D. Gallwey, Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21(11), 1440\u20131447 (1961). https:\/\/doi.org\/10.1210\/jcem-21-11-1440","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2596_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/humupd\/dmp024","volume":"16","author":"BO Yildiz","year":"2010","unstructured":"B.O. Yildiz, S. Bolour, K. Woods, A. Moore, R. Azziz, Visually scoring hirsutism. Hum. Reprod. Update 16(1), 51\u201364 (2010). https:\/\/doi.org\/10.1093\/humupd\/dmp024","journal-title":"Hum. Reprod. Update"},{"issue":"6","key":"2596_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18(6), 499\u2013502 (1972)","journal-title":"Clin. Chem."},{"issue":"7","key":"2596_CR21","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412\u2013419 (1985)","journal-title":"Diabetologia"},{"issue":"9","key":"2596_CR22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9), 1462\u20131470 (1999)","journal-title":"Diabetes Care"},{"issue":"5","key":"2596_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/medicina55050158","volume":"55","author":"D Hor\u00e1kov\u00e1","year":"2019","unstructured":"D. Hor\u00e1kov\u00e1, L. \u0160t\u011bp\u00e1nek, V. Janout, J. Janoutov\u00e1, D. Pastucha, H. Koll\u00e1rov\u00e1, A. Petr\u00e1kov\u00e1, R. Hus\u00e1r, K. Martin\u00edk, Optimal homeostasis model assessment of insulin resistance (HOMA-IR) cut-offs: a cross-sectional study in the Czech population. Med. (Kaunas.) 55(5), 158 (2019). https:\/\/doi.org\/10.3390\/medicina55050158","journal-title":"Med. (Kaunas.)"},{"key":"2596_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-13-47","volume":"13","author":"P Gayoso-Diz","year":"2013","unstructured":"P. Gayoso-Diz, A. Otero-Gonz\u00e1lez, M.X. Rodriguez-Alvarez, F. Gude, F. Garc\u00eda, A. De Francisco, A.G. Quintela, Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr. Disord. 13, 47 (2013). https:\/\/doi.org\/10.1186\/1472-6823-13-47","journal-title":"BMC Endocr. Disord."},{"issue":"4","key":"2596_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.20344\/amp.5180","volume":"27","author":"AT Tim\u00f3teo","year":"2014","unstructured":"A.T. Tim\u00f3teo, F. Miranda, M.M. Carmo, R.C. Ferreira, Optimal cut-off value for homeostasis model assessment (HOMA) index of insulin-resistance in a population of patients admitted electively in a Portuguese cardiology ward. Acta Med Port. 27(4), 473\u2013479 (2014). https:\/\/doi.org\/10.20344\/amp.5180","journal-title":"Acta Med Port."},{"issue":"6","key":"2596_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/humupd\/dmg044","volume":"9","author":"AH Balen","year":"2003","unstructured":"A.H. Balen, J.S. Laven, S.L. Tan, D. Dewailly, Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum. Reprod. Update 9(6), 505\u2013514 (2003). https:\/\/doi.org\/10.1093\/humupd\/dmg044","journal-title":"Hum. Reprod. Update"},{"issue":"12","key":"2596_CR27","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1111\/j.1471-0528.2009.02347.x","volume":"116","author":"HY Zhang","year":"2009","unstructured":"H.Y. Zhang, F.F. Zhu, J. Xiong, X.B. Shi, S.X. Fu, Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. Bjog 116(12), 1633\u20131639 (2009). https:\/\/doi.org\/10.1111\/j.1471-0528.2009.02347.x","journal-title":"Bjog"},{"issue":"7","key":"2596_CR28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/jog.12985","volume":"42","author":"E Bil","year":"2016","unstructured":"E. Bil, B. Dilbaz, D.A. Cirik, R. Ozelci, E. Ozkaya, S. Dilbaz, Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype. J. Obstet. Gynaecol. Res. 42(7), 837\u2013843 (2016). https:\/\/doi.org\/10.1111\/jog.12985","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"4","key":"2596_CR29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/cen.12008","volume":"78","author":"D Panidis","year":"2013","unstructured":"D. Panidis, D. Macut, K. Tziomalos, E. Papadakis, K. Mikhailidis, E.A. Kandaraki, E.A. Tsourdi, T. Tantanasis, G. Mavromatidis, I. Katsikis, Prevalence of metabolic syndrome in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 78(4), 586\u2013592 (2013). https:\/\/doi.org\/10.1111\/cen.12008","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"6","key":"2596_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/eje-16-0775","volume":"175","author":"I Bozic-Antic","year":"2016","unstructured":"I. Bozic-Antic, D. Ilic, J. Bjekic-Macut, T. Bogavac, D. Vojnovic-Milutinovic, B. Kastratovic-Kotlica, N. Milic, O. Stanojlovic, Z. Andric, D. Macut, Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome. Eur. J. Endocrinol. 175(6), 551\u2013560 (2016). https:\/\/doi.org\/10.1530\/eje-16-0775","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"2596_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.fertnstert.2007.11.057","volume":"91","author":"S Arikan","year":"2009","unstructured":"S. Arikan, H. Akay, M. Bahceci, A. Tuzcu, D. Gokalp, The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function. Fertil. Steril. 91(2), 450\u2013455 (2009). https:\/\/doi.org\/10.1016\/j.fertnstert.2007.11.057","journal-title":"Fertil. Steril."},{"issue":"4","key":"2596_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5468\/ogs.2013.56.4.249","volume":"56","author":"JJ Kim","year":"2013","unstructured":"J.J. Kim, Y.M. Choi, J.H. Kang, K.R. Hwang, S.J. Chae, S.M. Kim, S.Y. Ku, S.H. Kim, J.G. Kim, S.Y. Moon, Carotid intima-media thickness in mainly non-obese women with polycystic ovary syndrome and age-matched controls. Obstet. Gynecol. Sci. 56(4), 249\u2013255 (2013). https:\/\/doi.org\/10.5468\/ogs.2013.56.4.249","journal-title":"Obstet. Gynecol. Sci."},{"issue":"9","key":"2596_CR33","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1093\/humrep\/deu180","volume":"29","author":"E Rees","year":"2014","unstructured":"E. Rees, R. Coulson, F. Dunstan, W.D. Evans, H.L. Blundell, S.D. Luzio, G. Dunseath, J.P. Halcox, A.G. Fraser, D.A. Rees, Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk. Hum. Reprod. 29(9), 2041\u20132049 (2014). https:\/\/doi.org\/10.1093\/humrep\/deu180","journal-title":"Hum. Reprod."},{"issue":"5","key":"2596_CR34","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1210\/jc.2004-2363","volume":"90","author":"A Vryonidou","year":"2005","unstructured":"A. Vryonidou, A. Papatheodorou, A. Tavridou, T. Terzi, V. Loi, I.A. Vatalas, N. Batakis, C. Phenekos, A. Dionyssiou-Asteriou, Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 90(5), 2740\u20132746 (2005). https:\/\/doi.org\/10.1210\/jc.2004-2363","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"2596_CR35","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1093\/humrep\/dem324","volume":"22","author":"M Luque-Ramirez","year":"2007","unstructured":"M. Luque-Ramirez, C. Mendieta-Azcona, F. Alvarez-Blasco, H.F. Escobar-Morreale, Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Hum. Reprod. 22(12), 3197\u20133203 (2007). https:\/\/doi.org\/10.1093\/humrep\/dem324","journal-title":"Hum. Reprod."},{"issue":"11","key":"2596_CR36","first-page":"1266","volume":"4","author":"Z Allameh","year":"2013","unstructured":"Z. Allameh, S. Rouholamin, A. Adibi, M. Mehdipour, M. Adeli, Does carotid intima-media thickness have relationship with polycystic ovary syndrome? Int J. Prev. Med 4(11), 1266\u20131270 (2013)","journal-title":"Int J. Prev. Med"},{"issue":"3","key":"2596_CR37","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s12020-019-01899-9","volume":"64","author":"MH Dahan","year":"2019","unstructured":"M.H. Dahan, G. Reaven, Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome. Endocrine 64(3), 685\u2013689 (2019). https:\/\/doi.org\/10.1007\/s12020-019-01899-9","journal-title":"Endocrine"},{"issue":"2","key":"2596_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.14310\/horm.2002.11176","volume":"5","author":"K Alexandraki","year":"2006","unstructured":"K. Alexandraki, A.D. Protogerou, T.G. Papaioannou, C. Piperi, G. Mastorakos, J. Lekakis, D. Panidis, E. Diamanti-Kandarakis, Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome. Hormones (Athens) 5(2), 126\u2013136 (2006)","journal-title":"Hormones (Athens)"},{"issue":"1","key":"2596_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1757-2215-4-19","volume":"4","author":"A Mohammadi","year":"2011","unstructured":"A. Mohammadi, M. Aghasi, L. Jodeiry-Farshbaf, S. Salary-Lac, M. Ghasemi-Rad, Evaluation of early atherosclerotic findings in women with polycystic ovary syndrome. J. Ovarian Res. 4(1), 19 (2011). https:\/\/doi.org\/10.1186\/1757-2215-4-19","journal-title":"J. Ovarian Res."},{"issue":"11","key":"2596_CR40","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/aogs.12964","volume":"95","author":"D Glintborg","year":"2016","unstructured":"D. Glintborg, M.H. Petersen, P. Ravn, A.P. Hermann, M. Andersen, Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls. Acta Obstet. Gynecol. Scand. 95(11), 1235\u20131243 (2016). https:\/\/doi.org\/10.1111\/aogs.12964","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"3","key":"2596_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4103\/ijem.IJEM_646_17","volume":"22","author":"D Jena","year":"2018","unstructured":"D. Jena, A.K. Choudhury, S. Mangaraj, M. Singh, B.K. Mohanty, A.K. Baliarsinha, Study of visceral and subcutaneous abdominal fat thickness and its correlation with cardiometabolic risk factors and hormonal parameters in polycystic ovary syndrome. Indian J. Endocrinol. Metab. 22(3), 321\u2013327 (2018). https:\/\/doi.org\/10.4103\/ijem.IJEM_646_17","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"1","key":"2596_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/humrep\/dem356","volume":"23","author":"T Cascella","year":"2008","unstructured":"T. Cascella, S. Palomba, I. De Sio, F. Manguso, F. Giallauria, B. De Simone, D. Tafuri, G. Lombardi, A. Colao, F. Orio, Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum. Reprod. 23(1), 153\u2013159 (2008). https:\/\/doi.org\/10.1093\/humrep\/dem356","journal-title":"Hum. Reprod."},{"key":"2596_CR43","doi-asserted-by":"publisher","unstructured":"Kojta, I., Chaci\u0144ska, M., B\u0142achnio-Zabielska, A. Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients 12(5) (2020). https:\/\/doi.org\/10.3390\/nu12051305","DOI":"10.3390\/nu12051305"},{"issue":"3","key":"2596_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/09513590.2015.1111327","volume":"32","author":"SH Zheng","year":"2016","unstructured":"S.H. Zheng, X.L. Li, Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS. Gynecol. Endocrinol. 32(3), 177\u2013183 (2016). https:\/\/doi.org\/10.3109\/09513590.2015.1111327","journal-title":"Gynecol. Endocrinol."},{"issue":"6","key":"2596_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.ultrasmedbio.2013.12.017","volume":"40","author":"LS Rallidis","year":"2014","unstructured":"L.S. Rallidis, K. Baroutsi, M. Zolindaki, M. Karagianni, C. Varounis, N. Dagres, J. Lekakis, M. Anastasiou-Nana, Visceral adipose tissue is a better predictor of subclinical carotid atherosclerosis compared with waist circumference. Ultrasound Med Biol. 40(6), 1083\u20131088 (2014). https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2013.12.017","journal-title":"Ultrasound Med Biol."},{"key":"2596_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejogrb.2017.08.011","volume":"217","author":"P Tripathy","year":"2017","unstructured":"P. Tripathy, A. Sahu, M. Sahu, A. Nagy, Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 217, 18\u201322 (2017). https:\/\/doi.org\/10.1016\/j.ejogrb.2017.08.011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"2596_CR47","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/humrep\/des456","volume":"28","author":"K Tziomalos","year":"2013","unstructured":"K. Tziomalos, I. Katsikis, E. Papadakis, E.A. Kandaraki, D. Macut, D. Panidis, Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome. Hum. Reprod. 28(3), 785\u2013793 (2013). https:\/\/doi.org\/10.1093\/humrep\/des456","journal-title":"Hum. Reprod."},{"issue":"2","key":"2596_CR48","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s12020-014-0340-9","volume":"48","author":"A Albu","year":"2015","unstructured":"A. Albu, S. Radian, S. Fica, C.G. Barbu, Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients. Endocrine 48(2), 696\u2013704 (2015). https:\/\/doi.org\/10.1007\/s12020-014-0340-9","journal-title":"Endocrine"},{"issue":"6","key":"2596_CR49","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"E. Diamanti-Kandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33(6), 981\u20131030 (2012). https:\/\/doi.org\/10.1210\/er.2011-1034","journal-title":"Endocr. Rev."},{"issue":"3","key":"2596_CR50","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40618-014-0215-1","volume":"38","author":"D Macut","year":"2015","unstructured":"D. Macut, I.B. Antic, J. Bjekic-Macut, Cardiovascular risk factors and events in women with androgen excess. J. Endocrinol. Invest 38(3), 295\u2013301 (2015). https:\/\/doi.org\/10.1007\/s40618-014-0215-1","journal-title":"J. Endocrinol. Invest"},{"issue":"5","key":"2596_CR51","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40618-015-0403-7","volume":"39","author":"H Li","year":"2016","unstructured":"H. Li, X. Xu, X. Wang, X. Liao, L. Li, G. Yang, L. Gao, Free androgen index and Irisin in polycystic ovary syndrome. J. Endocrinol. Invest 39(5), 549\u2013556 (2016). https:\/\/doi.org\/10.1007\/s40618-015-0403-7","journal-title":"J. Endocrinol. Invest"},{"issue":"12","key":"2596_CR52","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1210\/jc.2015-2546","volume":"100","author":"B Fenske","year":"2015","unstructured":"B. Fenske, H. Kische, S. Gross, H. Wallaschofski, H. Volzke, M. Dorr, M. Nauck, B.G. Keevil, G. Brabant, R. Haring, Endogenous androgens and sex hormone-binding globulin in women and risk of metabolic syndrome and Type 2 Diabetes. J. Clin. Endocrinol. Metab. 100(12), 4595\u20134603 (2015). https:\/\/doi.org\/10.1210\/jc.2015-2546","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2596_CR53","doi-asserted-by":"publisher","first-page":"H3043","DOI":"10.1152\/ajpheart.00190.2006","volume":"291","author":"BA Parker","year":"2006","unstructured":"B.A. Parker, S.J. Ridout, D.N. Proctor, Age and flow-mediated dilation: a comparison of dilatory responsiveness in the brachial and popliteal arteries. Am. J. Physiol. Heart Circ. Physiol. 291(6), H3043\u20133049 (2006). https:\/\/doi.org\/10.1152\/ajpheart.00190.2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"2596_CR54","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.0000112565.60887.1E","volume":"109","author":"EJ Benjamin","year":"2004","unstructured":"E.J. Benjamin, M.G. Larson, M.J. Keyes, G.F. Mitchell, R.S. Vasan, J.F. Keaney, B.T. Lehman, S. Fan, E. Osypiuk, J.A. Vita, Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 109(5), 613\u2013619 (2004). https:\/\/doi.org\/10.1161\/01.CIR.0000112565.60887.1E","journal-title":"Circulation"},{"issue":"22","key":"2596_CR55","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1016\/j.jacc.2018.01.083","volume":"71","author":"D Zhao","year":"2018","unstructured":"D. Zhao, E. Guallar, P. Ouyang, V. Subramanya, D. Vaidya, C.E. Ndumele, J.A. Lima, M.A. Allison, S.J. Shah, A.G. Bertoni, M.J. Budoff, W.S. Post, E.D. Michos, Endogenous sex hormones and incident cardiovascular disease in post-menopausal women. J. Am. Coll. Cardiol. 71(22), 2555\u20132566 (2018). https:\/\/doi.org\/10.1016\/j.jacc.2018.01.083","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"2596_CR56","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3275\/9023","volume":"36","author":"LJ Moran","year":"2013","unstructured":"L.J. Moran, H.J. Teede, M. Noakes, P.M. Clifton, R.J. Norman, G.A. Wittert, Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome. J. Endocrinol. Invest. 36(11), 1004\u20131010 (2013). https:\/\/doi.org\/10.3275\/9023","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"2596_CR57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"V. Ormazabal, S. Nair, O. Elfeky, C. Aguayo, C. Salomon, F.A. Zuniga, Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 17(1), 122 (2018). https:\/\/doi.org\/10.1186\/s12933-018-0762-4","journal-title":"Cardiovasc Diabetol."},{"issue":"9","key":"2596_CR58","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"H.J. Teede, M.L. Misso, M.F. Costello, A. Dokras, J. Laven, L. Moran, T. Piltonen, R.J. Norman, Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 33(9), 1602\u20131618 (2018). https:\/\/doi.org\/10.1093\/humrep\/dey256","journal-title":"Hum. Reprod."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02596-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02596-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02596-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T10:20:55Z","timestamp":1621246855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02596-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2596"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02596-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"2 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Medical University of Bialystok (approval No. R-I-002\/221\/2016).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}